Drug Substance and Excipient Characterization

Characterization of drug substances and excipients is a very important step at the preformulation phase of product development. Although testing will involve addi- tional time and cost, failure to carry out the appropriate characterization tests can be even more costly to manufacturers if the product made is not within specifi- cations. Preformulation characterization of raw materials creates a body of infor- mation which is very useful in the development of products. The lack of such information leaves the formulator with little leeway for remediation action when a problem arises from the production process or from the quality of the finished product. It is important to eliminate the possible influences of the raw material char- acteristics before venturing into investigation of processing variables. The knowledge derived from the characterization of raw materials can also serve to enable better specifications to be drawn up for procuring materials with the aim of either reducing cost or improving product quality. In addition, a review of material characterization results can provide an excellent database for the assessment of suppliers who can provide materials of consistent quality. Materials from reputable companies may be supplied with detailed speci- fications and their methods of determination may be obtained, if requested. The information on specifications such as purity or content is very often available. Nevertheless, it is prudent to confirm such information. The information provided by different suppliers may vary. The type of tests carried out or the techniques used for the characterization of a particular physical property, for example, the particle size distribution, may be different. Comparison of materials from different suppliers can therefore be difficult. Sometimes, the analytical result supplied by the manufac- turer is given as falling within a certain range and this gives virtually no information about batch to batch variation of the material. It is therefore important to have a system of in-house characterization of raw materials alongside the stability and functional tests for the finished product. When- ever possible, tests carried out should yield quantitative results rather than a pass/ fail or present/absent assessment. Retrospective studies of the finished product test

[1]  A. G. Flook The use of dilation logic on the quantimet to achieve fractal dimension characterisation of textured and structured profiles , 1978 .

[2]  W. Mccrone,et al.  Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.

[3]  P. York,et al.  Interaction phenomena in pharmaceutical film coatings and testing methods , 1987 .

[4]  H. Wadell Volume, Shape, and Roundness of Rock Particles , 1932, The Journal of Geology.

[5]  K. Florey,et al.  Analytical profiles of drug substances and excipients , 1992 .

[6]  Z. Chowhan EXCIPIENTS AND THEIR FUNCTIONALITY IN DRUG PRODUCT DEVELOPMENT , 1993 .

[7]  Peter Ridgway Watt Tablet machine instrumentation in pharmaceutics : principles and practice , 1988 .

[8]  Brian H. Kaye,et al.  Multifractal Description of a Rugged Fineparticle Profile , 1984 .

[9]  Sarsvatkumar Patel,et al.  Effect of Particle Size and Compression Force on Compaction Behavior and Derived Mathematical Parameters of Compressibility , 2006, Pharmaceutical Research.

[10]  J. Russ Computer-Assisted Microscopy , 1990, Springer US.

[11]  M. Yamashiro,et al.  An experimental study on the relationships between compressibility, fluidity and cohesion of powder solids at small tapping numbers , 1983 .

[12]  M. Lai,et al.  Characterization of Powders , 1998 .

[13]  A. Blumen D. Avnir (Ed.): The Fractal Approach to Heterogeneous Chemistry, J. Wiley and Sons, Chichester, New York, Brisbane, Toronto, Singapore 1989. 441 Seiten, Preis: £ 75.—. , 1990 .

[14]  H. Heywood THE EVALUATION OF POWDERS , 1963, The Journal of pharmacy and pharmacology.

[15]  B. H. Kaye Specification of the ruggedness and/or texture of a fine particle profile by its fractal dimension , 1978 .

[16]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[17]  G. Zografi,et al.  The Quantitative Analysis of Crystallinity Using FT-Raman Spectroscopy , 1998, Pharmaceutical Research.

[18]  D. Bugay,et al.  Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. , 1998, Journal of pharmaceutical and biomedical analysis.

[19]  V. Timbrell A Method of Measuring and Grading Microscopic Spherical Particles , 1952, Nature.

[20]  R. Bottom The role of modulated temperature differential scanning calorimetry in the characterisation of a drug molecule exhibiting polymorphic and glass forming tendencies. , 1999, International journal of pharmaceutics.